Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sancho, M. Gallego, C. Montón, X. Pomares, D. Mariscal, E. Castañer, A. Marin (Sabadell, Spain). Influence of bronchiectasis in COPD exacerbations caused by pseudomonas aeruginosa. Eur Respir J 2009; 34: Suppl. 53, 1363

Member's Comments

No comment yet.

Related content which might interest you: Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 The effect of bronchiectasis on asthma exacerbations Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis Source: Eur Respir Rev 2015; 24: 451-461 Year: 2015 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Impact of halotherapy on COPD exacerbations Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Impact of exacerbations on COPD Source: Eur Respir Rev 2009; 19: 113-118 Year: 2010 Defining the contribution of emphysema and chronic bronchitis in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003 Effect of noninvasive ventilation on interleukin-8 in COPD exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Management of COPD exacerbations Source: ERS Lung Science Conference 2019 Year: 2019